Obtacles and opportunities in the clinical development of targeted therapeutics

作者: Grace K. Dy , Alex A. Adjei

DOI: 10.1007/3-7643-7414-4_2

关键词:

摘要:

参考文章(75)
Bharat B. Aggarwal, Nuclear factor-κB: The enemy within Cancer Cell. ,vol. 6, pp. 203- 208 ,(2004) , 10.1016/J.CCR.2004.09.003
Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press, Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood. ,vol. 91, pp. 1644- 1652 ,(1998) , 10.1182/BLOOD.V91.5.1644
Steven A. Rosenberg, Vincent T. DeVita, Samuel Hellman, Cancer : Principles and Practice of Oncology ,(1982)
Tony DeBlasio, Zhen Fan, Yang Lu, Ding Peng, John Mendelsohn, Howard Scher, Howard Scher, Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Research. ,vol. 56, pp. 3666- 3669 ,(1996)
Mark G. Kris, Howard I. Scher, Vincent A. Miller, Maureen F. Zakowski, Francis M. Sirotnak, Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase Clinical Cancer Research. ,vol. 6, pp. 4885- 4892 ,(2000)
Vincent A. Pollack, Catherine DiOrio, April Theleman, Elsa G. Barbacci, Leslie R. Pustilnik, Mark Neveu, Mikel P. Moyer, Kenneth K. Iwata, Lee Arnold, Michael J. Morin, James D. Moyer, Bruce Boman, Penny Miller, Ann Cunningham, Margaret M. Reynolds, Don Sloan, Jonathan Doty, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Research. ,vol. 57, pp. 4838- 4848 ,(1997)
Edward L. Korn, Susan G. Arbuck, James M. Pluda, Richard Simon, Richard S. Kaplan, Michaele C. Christian, Clinical Trial Designs for Cytostatic Agents: Are New Approaches Needed? Journal of Clinical Oncology. ,vol. 19, pp. 265- 272 ,(2001) , 10.1200/JCO.2001.19.1.265
Donald Podoloff, Isis Gayed, Marcella Johnson, Revathy Iyer, Homer Macapinlac, Nancy Swanston, Thuan Vu, The Role of 18F-FDG PET in Staging and Early Prediction of Response to Therapy of Recurrent Gastrointestinal Stromal Tumors The Journal of Nuclear Medicine. ,vol. 45, pp. 17- 21 ,(2004)
Anita F.W. Frijhoff, Claudio J. Conti, Adrian M. Senderowicz, Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs. Molecular Carcinogenesis. ,vol. 39, pp. 183- 194 ,(2004) , 10.1002/MC.20013